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Triclosan (TCS) is a commonly used antimicrobial agent that enters wastewater treatment
plants (WWTPs) and the environment. An estimated 1.1 × 105 to 4.2 × 105 kg of TCS
are discharged from these WWTPs per year in the United States. The abundance of TCS
along with its antimicrobial properties have given rise to concern regarding its impact on
antibiotic resistance in the environment. The objective of this review is to assess the
state of knowledge regarding the impact of TCS on multidrug resistance in environmental
settings, including engineered environments such as anaerobic digesters. Pure culture
studies are reviewed in this paper to gain insight into the substantially smaller body of
research surrounding the impacts of TCS on environmental microbial communities. Pure
culture studies, mainly on pathogenic strains of bacteria, demonstrate that TCS is often
associated with multidrug resistance. Research is lacking to quantify the current impacts
of TCS discharge to the environment, but it is known that resistance to TCS and multidrug
resistance can increase in environmental microbial communities exposed to TCS. Research
plans are proposed to quantitatively define the conditions under which TCS selects for
multidrug resistance in the environment.
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INTRODUCTION
The World Health Organization warns that we may enter a post-
antibiotic era in the twenty-first century due to the spread of
antibiotic resistance (World Health Organization [WHO], 2014).
Antibiotic resistance is defined as the ability of bacteria to survive
a concentration of antibiotics that typically inhibits growth of the
majority of other bacteria (Russell, 2000). Antibiotics are exten-
sively used in medicine to treat bacterial infections in humans
and animals, and are widely used in agriculture to promote
animal growth (Khachatourians, 1998; Kümmerer, 2004). Each
year, in the United States (U.S.) alone, over two million people
are infected by antibiotic resistant bacteria, leading to more than
25,000 deaths, and $50 billion spent managing antibiotic resis-
tance (Centers for Disease Control and Prevention [CDC], U.S.
Department of Health, and Human Services, 2013). The associ-
ated cost continues to increase as bacteria acquire mechanisms to
fight against the antibiotics that are typically employed (Levy and
Marshall, 2004).
In addition to antibiotics, synthetic antimicrobial agents are
also pervasive in households and hospitals, mainly for disin-
fection and sanitation purposes. The term “antimicrobial” has
been used to describe a broad range of compounds, including
antibiotics that destroy or inhibit microorganisms (McDonnell
and Russell, 1999; Kümmerer, 2004). For this paper, triclosan
(TCS), which is not derived naturally, is referred to as an
antimicrobial. Compounds produced or derived from microor-
ganisms used in vivo to treat bacterial infections in eukary-
otes (e.g., erythromycin, tetracycline, ciprofloxacin, etc.) will be
referred to as antibiotics (even though antibiotics are a subset of
antimicrobials).
Triclosan is widely used for personal hygiene and disinfection
purposes; in fact, 350 tons were produced for commercial use in
the European Union in 2002. Based on 1998 records from the
Environmental Protection Agency, approximately 500–5000 tons
were produced in the U.S., and the industry has reported growth
(Singer et al., 2002; Heidler and Halden, 2007; Fang et al., 2010;
Venkatesan and Halden, 2014). With these approximations, it is
estimated that 1 kg of TCS is produced for every 3 kg of antibiotics
produced (Food and Drug Administration [FDA], 2011; Depart-
ment of Health and Human Services [DHHS], 2012). TCS is
found in a wide range of consumer products including hand soap,
toothpaste, deodorant, surgical scrubs, shower gel, hand lotion,
hand cream, and mouthwash (Bhargava and Leonard, 1996; Jones
et al., 2000).
Because of its wide use, TCS is found in many natural and engi-
neered environments, including surface water, wastewater, soil,
drinking water, wastewater treatment plants (WWTPs), biosolids,
landfills, and sediments (Singer et al., 2002; Miller and Heidler,
2008; Benotti et al., 2009; Kumar et al., 2010; Xia et al., 2010;
Welsch and Gillock, 2011; Bedoux et al., 2012; Mavri et al., 2012).
As TCS is commonly used in oral consumer products, it is widely
found in human urine. In a survey of 181 pregnant women in an
urban multiethnic population in Brooklyn, NY, TCS was found
in 100% of urine samples (Pycke et al., 2014). In a geographically
broader U.S. survey, 75% of people were found to have TCS in
their urine (Calafat et al., 2008).
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At application concentrations (0.1–0.3 w/v% or approximately
1,000–3,000 mg/L in hand soaps), TCS induces cell damage that
causes cell contents to physically leak out of the membrane
(Villalaín et al., 2001). At concentrations lower than 1 mg/L, TCS
serves as an external pressure to select for TCS resistance as well
as antibiotic resistance in many types of bacteria (Russell, 2000;
Schweizer, 2001; Poole, 2002; Chapman, 2003; Yazdankhah et al.,
2006; Birosová and Mikulásová, 2009; Saleh et al., 2011; Halden,
2014). At low concentrations, TCS interacts with physiological
targets, and these interactions lead to numerous resistance mech-
anisms that are reviewed below (Chuanchuen et al., 2001; Bailey
et al., 2008; Yu et al., 2010; Condell et al., 2012). In some cases,
the mechanisms that convey resistance to TCS simultaneously
confer resistance to more than one class of antibiotics (Poole,
2002; Alanis, 2005).
The wide use of TCS leads to concern about its potential to
aid in the spread of antibiotic resistance (Russell, 2000; Küm-
merer, 2004; Saleh et al., 2011). TCS exposure that leads to TCS
resistance and antibiotic resistance has been widely reported, but
the majority of these studies pertain to pure cultures of specific
bacterial strains, and in most cases, pathogenic strains. This line
of research is logical because antibiotic resistant pathogens are
of greatest concern to public health. TCS might also impact the
spread of resistance in environmental microbial communities as
approximately 1.1 × 105 to 4.2 × 105 kg of TCS are distributed
to the environment annually through WWTPs in the U.S. (Hei-
dler and Halden, 2007). Studies on pure culture isolates provide
insight into the potential impacts of TCS on antibiotic resistance
in environmental bacterial communities. The important question
then becomes: does TCS select for antibiotic resistance in these
complex microbial communities?
Many engineered and natural processes are driven by
microbes, and TCS is designed to impact microbes in homes and
hospitals. Following discharge to the environment, the antimi-
crobial properties of TCS can impact complex microbial com-
munities found in engineered and environmental systems. TCS
has been linked to altering microbial community structure or
function in wastewater operations, such as activated sludge and
anaerobic digestion (Stasinakis et al., 2008; McNamara et al.,
2014). Likewise, TCS can alter diversity and biofilm development
in freshwater biofilms in receiving streams (Johnson et al., 2009;
Proia et al., 2011; Lubarsky et al., 2012). In soils, TCS impacts
respiration rates and denitrification, and enriches for species
capable of dehalogenation (Butler et al., 2011; McNamara and
Krzmarzick, 2013; Holzem et al., 2014). TCS induces responses in
microbial communities, but the TCS concentrations that inhibit
function are not often found in these complex microbial com-
munities. At environmental concentrations, TCS is more likely to
exert a stress that propagates resistance than to exert a stress that
functionally inhibits complex microbial communities.
The purpose of this manuscript is to review the state of
knowledge regarding the impact of TCS on antibiotic resistance
in environmental systems and identify critical research questions
that need to be addressed to better understand the impact of
TCS-derived resistance in the environment on public health.
This review describes TCS resistance and cross-resistance in pure
cultures, and then considers the comparatively smaller amount
of literature that addresses how TCS impacts antibiotic resistance
in engineered environments containing complex microbial com-
munities. Engineered environments are of prime interest because
they contain TCS, bacteria, and resistance genes that can be
subsequently dispersed to terrestrial soils and surface waters with
the possibility of negative public health consequences (Pruden
et al., 2006, 2012; Baquero et al., 2008; Cha and Cupples, 2009;
Ghosh et al., 2009; Munir et al., 2010; LaPara et al., 2011; Ma et al.,
2011; Burch et al., 2014; Yang et al., 2014).
GENETIC TARGETS OF TRICLOSAN
In 1998, TCS was first described by McMurry et al. (1998b) to have
a specific target in Escherichia coli. At 1 mg/L, approximately 1000-
fold lower than the application concentration, TCS inhibits FabI,
an enoyl-acyl carrier protein reductase (ENR). The FabI protein
catalyzes the elongation cycle in the synthesis of fatty acids, an
essential process for cell viability (Bergler et al., 1996; Massengo-
Tiassé and Cronan, 2008, 2009). Prior to McMurry et al.’s (1998b)
report, low concentrations of TCS were assumed to have minimal
effects on cell viability.
Up-regulation of fabI is a response mechanism which may
overcome the effects of intracellular TCS (Condell et al., 2012; Yu
et al., 2012; Sheridan et al., 2013). Bacteria can up-regulate and
down-regulate many more genes in response to TCS, although
it can be difficult to determine which expression changes are
casual. No universal response has been observed; however, many
bacteria respond to some degree with the up-regulation of trans-
port proteins and membrane bound proteins (Bailey et al., 2008;
Chuanchuen and Schweizer, 2012).
TCS RESISTANCE IN PURE CULTURES
The most common resistance mechanisms based on pure culture
studies are target site modification, membrane resistance, and
efflux. The following sections briefly review resistance mech-
anisms to TCS and describe their impact on cross-resistance;
a comprehensive review of TCS resistance mechanisms can be
found by Schweizer (2001).
FABI MODIFICATION OR REPLACEMENT
Target site modification is a resistance mechanism that involves
a genetic alteration to the target site that reduces the effect of an
inhibitory chemical (Hooper, 2005). Modification of TCS target
site FabI is a common resistance mechanism observed in pure cul-
tures. Mutation occurs whereby single or multiple amino acids are
changed in the fabI gene, resulting in TCS-resistant FabI proteins
(Brenwald and Fraise, 2003; Yu et al., 2010). Ciusa et al. (2012)
suggested a resistance mechanism whereby an allele of a fabI
gene is located on a mobile genetic element and transposed into
Staphylococcus aureus. The presence of the fabI allele together with
the intrinsic fabI gene increased the concentration of the FabI
protein through heterologous duplication and increased bacterial
tolerance to TCS. Alternatively, ENR isoenzymes, which perform
similar functions to FabI, including FabL, FabK, and FabV, have
been identified in TCS-resistant bacteria (Massengo-Tiassé and
Cronan, 2009). These isoenzymes are naturally found in some
strains of bacteria. In fact, FabV has been found to functionally
replace FabI, rendering Pseudomonas aeruginosa 2,000 times more
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resistant to TCS as seen by an increase in minimum inhibitory
concentration (MIC; Zhu et al., 2010). Similarly, FabK replaces
function for FabI in Streptococcus pneumonia, leading to increased
tolerance to TCS (Heath et al., 2000), and FabL expression leads to
increased resistance to TCS in Bacillus subtilis (Heath et al., 2000).
With respect to multidrug resistance, FabI alteration or
replacement may specifically produce resistance to isoniazid, an
important agent for the treatment of tuberculosis, which also
targets FabI (Ciusa et al., 2012). However, FabI alterations are not
generally known to cause resistance to other antibiotics. This type
of resistance in environmental communities would not likely pose
a threat to public health through increased multidrug resistance.
MEMBRANE ALTERATION
Modifications through changes to the outer membrane is a less-
studied TCS resistance mechanism in bacteria. Champlin et al.
(2005) concluded that outer membrane properties were respon-
sible for low-level resistance to hydrophobic antimicrobials and
antibiotics. The researchers compared P. aeruginosa strains that
possessed highly refractory outer cell envelopes to strains that
had highly permeable outer cell envelopes and discovered that
the outer membrane properties conferred intrinsic resistance to
TCS up to 256 mg/L. Tkachenko et al. (2007) suggested that TCS
exposure could induce a genetic response which increases the
concentration of branched chain fatty acids in the cell membrane
in S. aureus; the membrane thereby sequesters the chemical agent
and stops it from passing into the cell, preventing physiological
disruption inside of the cell.
Outer membrane impermeability is a potential mechanism for
cross-resistance to antibiotics. Particularly, non-specific rejection
of hydrophobic chemicals could be a mechanism for resistance to
TCS and other antibiotics that may be found in the environment.
EFFLUX PUMPS
Efflux pumps are often associated with multidrug resistance,
which is a public health concern. Active efflux, whereby a bac-
terium physically removes a constituent from its intracellular
space by pumping the constituent across the membrane and
back into the environment, is an effective mechanism against a
wide range of antimicrobials and antibiotics, including TCS (Kern
et al., 2000; Levy, 2002). The AcrAB efflux pump is responsible
for efflux of TCS in E. coli and Salmonella enterica (McMurry
et al., 1998a; Webber et al., 2008). Non-specific multidrug efflux
pumps (e.g., mex proteins) confer resistance to TCS as well as
other antibiotics in P. aeruginosa and Rhodospirillum rubrum
(Chuanchuen et al., 2001; Pycke et al., 2010a,b). Most non-
specific efflux pumps are capable of expulsing antibiotics. Thus,
in cases where bacteria acquire non-specific efflux pumps through
horizontal gene transfer after exposure to TCS, the bacteria would
likely acquire resistance to antibiotics as well. In some cases
specific efflux pumps confer resistance to TCS. TriABC-OpmH is
a TCS-specific efflux pump in P. aeruginosa that is not known to
expel other compounds such as antibiotics (Mima et al., 2007).
TRICLOSAN AND CROSS-RESISTANCE TO ANTIBIOTICS
Resistance to TCS, incurred by exposure to TCS, can directly
affect resistance to antibiotics. Cross-resistance has been tested
for a wide range of antibiotics following exposure to TCS.
Chloramphenicol and tetracycline are two antibiotics commonly
included in antibiotic cross-resistance experiments. In studies
done on E. coli and P. aeruginosa, resistance to chlorampheni-
col and tetracycline increased 10-fold following TCS exposure
(Figure 1). Increased antibiotic resistance in Stenotrophomonas
maltophilia and Salmonella enterica serovar Typhimurium fol-
lowing TCS exposure was also observed, but the increase was
less severe. Cross resistance in P. aeruginosa (Chuanchuen et al.,
2001), Stenotrophomonas maltophilia (Sanchez et al., 2005), and
Salmonella enterica serovar Typhimurium (Karatzas et al., 2007)
were attributed to efflux systems. Resistance mechanisms were
not directly investigated in the studies on E. coli (Braoudaki
and Hilton, 2004) and Salmonella enterica serovar Typhimurium
(Birosová and Mikulásová, 2009), however acrAB genes, which
encode for efflux, are known to confer resistance to TCS, chlo-
ramphenicol, and tetracycline in both of these species (Karatzas
et al., 2007). These findings highlight a main concern regarding
the widespread dissemination of TCS, i.e., that TCS exposure can
spread multidrug resistance.
Triclosan resistance and antibiotic resistance have been found
together in clinical isolates. In a survey of 732 clinical isolates
of Acinetobacter baumannii from hospitals, 3% of isolates were
found to have reduced susceptibility to TCS (MIC > 1 mg/L;
Chen et al., 2009). Those isolates which could tolerate higher than
4 mg/L also had increased tolerance to amikacin, tetracycline, lev-
ofloxacin and imipenem. Clinical isolates of S. aureus, which had
MICs to TCS between 0.025 and 1 mg/L, were resistant to multiple
antibiotics (Suller and Russell, 2000). Some, but not all, of the
strains showed increased resistance to gentamicin, erythromycin,
penicillin, rifampicin, fusidic acid, tetracycline, methicillin,
mupirocin, and streptomycin. In some strains TCS resistance was
stable when sub-culturing was performed in a TCS-free medium.
In other strains TCS resistance was lost when the strain was prop-
agated for 10 days in TCS-free media, indicating that the presence
of TCS can select for resistance that is not regularly expressed.
This finding implies that removing TCS from environmental sys-
tems through improved treatment processes or reduced consumer
usage could lead to a decrease in TCS resistance. Research should
be conducted to specifically test the impacts of removing TCS on
TCS-derived resistance in complex microbial communities.
Conditions that perpetuate resistance to TCS frequently result
in cross-resistance to antibiotics. TCS resistant Salmonella enterica
serovar Typhimurium strains were selected by daily sub-culturing
of TCS-exposed cultures and increasing TCS concentrations in
media from 0.05 to 15 mg/L over 15 days (Karatzas et al., 2007).
The TCS MIC in the resulting strains increased from 0.06 mg/L
to as high as 128 mg/L, and the strains were also more resistant to
ampicillin, tetracycline, and kanamycin. The authors concluded
that the overexpression of the acrAB efflux pump was likely
involved in the increased tolerance to TCS and antibiotics. In
another study, TCS selected for ciprofloxacin resistant mutants
in Salmonella enterica serovar Typhimurium when exposed to
0.5 mg/L of TCS (Birosová and Mikulásová, 2009). These studies,
along with the concentrations of TCS found in the environment,
imply that TCS could select for bacteria in environmental com-
munities that have efflux pumps.
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FIGURE 1 | Triclosan exposure increases resistance to antibiotics.
Minimum inhibitory concentrations of chloramphenicol and tetracycline for
control strains (striped bars) and TCS adapted strains (solid bars) are shown
from various studies and bacteria. Differences were observed in most cases,
however, no difference was found for tetracycline resistance for Salmonella
enterica in the study by Birosová and Mikulásová (2009). Chloramphenicol
resistance was not tested in Pseudomonas aeruginosa (Chuanchuen et al.,
2001).
Efflux is a common method of resistance, but the specific efflux
system used and the resulting cross-resistance profile can vary
between species. In P. aeruginosa, MexAB-OprM, MexCD-OprJ,
and MexEF-OprN, contribute to TCS resistance (Chuanchuen
et al., 2001). Exposure to TCS selected for up-regulation of
these efflux systems due to mutations in the regulatory gene,
nfxB, which increased the tolerance to tetracycline, ciprofloxacin,
trimethoprim, erythromycin, and gentamicin. In some cases the
TCS resistant strains could tolerate up to 500-fold higher antibi-
otic concentrations than the non-TCS resistant strains. Strains
which lacked these efflux systems showed increased sensitivity to
antibiotics. In the opportunistic pathogen Stenotrophomonas mal-
tophilia, TCS binds to the repressor SmeT, allowing expression of
an efflux pump, SmeDEF (Hernández et al., 2011). Expression of
this efflux pump following exposure to TCS resulted in increased
resistance to the antibiotics ciprofloxacin, norfloxacin, nalidixic,
and ofloxacin. Sanchez et al. (2005) also found that TCS-resistant
mutants of Stenotrophomonas maltophilia (tolerant up to 64 µg/L
of TCS) overexpress SmeDEF. These mutants had an increased
tolerance to tetracycline, chloramphenicol, and ciprofloxacin.
Even though SmeDEF is intrinsically contained in the genome
of Stenotrophomonas maltophilia, TCS exposure selected for
up-regulation of this efflux pump which increased antibiotic
resistance.
In addition to variances between genera, cross-resistance varies
within genera. TCS-adapted E. coli O157:H7 exhibited increased
resistance to chloramphenicol, tetracycline, amoxicillin, amoxi-
cillin/clavulanic acid, trimethoprim, benzalkonium chloride, and
chlorhexidine, while TCS-adapted E. coli O55 exhibited resistance
to only trimethoprim (Braoudaki and Hilton, 2004).
Although most evidence supports the notion that TCS
increases resistance to antibiotics, this is not necessarily true for
all classes of antibiotics. In one case, TCS-resistant mutants of
Salmonella enterica were more (or no less) susceptible to antibi-
otics (Rensch et al., 2013). Salmonella enterica that were selected
to have overexpression of fabI or a fabI mutation had increased
susceptibility to the aminoglycoside antibiotics kanamycin and
gentamicin.
The cross-resistance profiles vary among the bacteria surveyed
in this review, and other types of bacteria yet to be studied are
likely to have unique cross-resistance profiles. While resistance
profiles vary, the overarching theme is the same: resistance to TCS
can yield cross-resistance to multiple antibiotics. Given that TCS
is not an antibiotic, resistance to TCS alone is not a public health
threat. TCS-derived proliferation of multidrug resistant bacteria,
however, could be a severe threat to public health. These pure
culture studies indicate that TCS is likely to select for multidrug
resistant bacteria above a critical concentration. In environmental
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communities, such as anaerobic digesters or sediments, TCS is
found at 2- to 1000-fold higher concentrations than any given
antibiotic (McClellan and Halden, 2010). Is TCS selecting for
resistant bacteria in the environment? The role of TCS on the
selection of antibiotic resistance genes and multidrug resistance
genes in the environment needs to be quantified to determine
what steps, if any, are necessary for protecting public health.
TRICLOSAN-DERIVED RESISTANCE IN COMPLEX
ENVIRONMENTAL COMMUNITIES
Environmental systems, including WWTPs and sediments, repre-
sent the most likely sites for TCS resistance to develop because of
the high abundance of TCS and high density of bacteria. Wastew-
ater treatment systems should be given special focus because
they contain and discharge TCS and resistance genes to the
environment. To understand the role of TCS and the remaining
research gaps, the fate of TCS in the environment is summarized
to highlight locations of prime interest, and the state of knowledge
regarding TCS and resistance in complex microbial communities
is assessed.
FATE OF TRICLOSAN
Triclosan is discharged into the environment with treated liquid
and solid effluents from WWTPs. In the U.S. alone, WWTPs are
estimated to receive approximately 100 tons of TCS each year,
but the prevalence of TCS in treated effluent is not restricted
to U.S. facilities. A survey of WWTPs in Germany found TCS
in treated effluents at concentrations ranging from 1 × 10−5 to
6 × 10−4 mg/L (Bester, 2005). The concentrations of TCS and
its aerobic degradation products in receiving waters were less
than 3 × 10−6 mg/L. A study of eight WWTPs in Switzerland
revealed that, on average, 6% of the influent TCS was found to
discharge with the effluent water at concentrations of 4.2 × 10−5
to 2.13 × 10−4 mg/L (Singer et al., 2002); these receiving streams
had concentrations at 1.1 × 10−5 to 9.8 × 10−5 mg/L. A more
recent study found TCS in WWTP effluents at 9.7 × 10−5 mg/L,
and in nearby sediments at 0.018 mg/kg (Blair et al., 2013). Several
other studies have found TCS in surface water in concentrations
ranging from <2 × 10−7 mg/L up to 0.022 mg/L (Bedoux et al.,
2012).
Triclosan that is discharged with liquid effluent often parti-
tions to sediments. Miller and Heidler (2008) found that TCS
accumulated in sediments near WWTP outfalls for approximately
50 years, and similar results were found by other researchers
(Buth et al., 2010; Anger et al., 2013). Sediment concentrations
have been found at 53 mg/kg (Chalew and Halden, 2009). TCS
is prevalent in liquid effluents and abundant in sediments, but
this discharge route does not account for the majority of TCS that
enters the environment. One study estimated that 0.24 kg/day of
TCS are released with liquid effluent, but 5.37 kg/day are released
with the treated residual solids from a midsized WWTP (Lozano
et al., 2013).
Indeed, nearly half (or even higher) of the influent TCS load
to WWTPs is captured by solids following sorption (Heidler
and Halden, 2007; Lozano et al., 2013). The concentration of
TCS in biosolids is often much higher than in aqueous systems
because of the hydrophobic nature of TCS (Heidler and Halden,
2008). A nationwide U.S. survey of TCS in biosolids found the
median concentration in treated biosolids to be 3.9 mg/kg and
the maximum level was 133 mg/kg (United States Environmental
Protection Agency [USEPA], 2009). The high levels found in
biosolids can lead to high levels in soils when biosolids are land
applied. TCS was found in biosolids-amended soils which had
been receiving biosolids for 33 years (Xia et al., 2010). The con-
centrations in the soil ranged from approximately 1 mg/kg in the
first 15 cm of soil to less than 0.1 mg/kg at a depth of 60–120 cm.
The half-life of TCS in soil under aerobic conditions was 104 days,
and TCS is even more persistent under anaerobic conditions
(McAvoy et al., 2002; Ying et al., 2007). These fate data, along with
the hydrophobic nature of TCS, indicate that TCS is most likely to
impact microbial communities that contain high concentrations
of organic matter, including anaerobic digesters, sediments, and
soils, and these communities should receive special focus when
investigating TCS-derived resistance in the environment.
The range of TCS concentrations found in the environment is
depicted in Figure 2 along with the MIC of TCS-acclimated and
TCS-unacclimated pathogenic strains of bacteria. The concentra-
tions in the biosolids and sediments are higher than the MICs
of TCS-sensitive strains, indicating that TCS-sensitive strains
would not thrive in these environments and TCS-resistant strains
may be present. The MICs of TCS-acclimated strains, however,
are higher than the current environmental TCS concentrations
and could tolerate an increase in TCS concentrations. A future
increase in TCS concentrations may select for resistance rather
than functionally inhibit complex microbial communities. This
figure indicates that biosolids and sediment environments with
high TCS concentrations likely have TCS-resistant bacteria, but
this figure does not indicate the level of TCS required to select
or enrich for resistance in the environments with lower TCS
concentrations. What happens when TCS is below the MIC? Cer-
tainly environments with very high levels of TCS will have TCS-
resistant strains, but do environments with TCS concentrations
below the MIC of acclimated strains select for resistance? What
concentration of TCS is required to select for resistance in various
environmental communities? These questions represent critical
research gaps. By answering these questions with further research
we can determine if and where TCS is selecting for resistance.
Research plans are outlined in the final section to address these
questions.
TRICLOSAN RESISTANCE IN COMPLEX MICROBIAL COMMUNITIES
Bacteria with resistance to TCS are found in the environment,
and experiments have been performed to determine whether TCS
could be the cause for resistance. Drury et al. (2013) constructed
artificial streams to control for other selective pressures such as
antibiotics. The artificial streams were inoculated with approxi-
mately 8 mg/L of TCS. Over 34 days, the relative abundance of
benthic bacteria which were able to be cultivated in 16 mg/L of
TCS in agar climbed from 0 to 14%. In a similar study, TCS was
added to artificial stream mesocosms at 1 × 10−4, 5 × 10−4,
1 × 10−3, 5 × 10−3, and 1 × 10−2 mg/L, and resistance to
TCS significantly increased in bacterial populations exposed to
TCS concentrations over 5 × 10−4 mg/L (Nietch and Quinlan,
2013). This study was conducted at environmentally relevant
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FIGURE 2 | The MIC of TCS-acclimated and TCS-unacclimated strains
relative to environmental TCS concentrations. Open symbols
represent the MIC for TCS sensitive strains, while closed symbols
represent the MIC for TCS adapted strains. Black bars are ranges of TCS
concentrations found in each environmental setting. Biosolids
concentrations were converted from mg/kg to mg/L by assuming 3% total
solids in reactors that produce biosolids (McMurry et al., 1998a, 1999;
Chuanchuen et al., 2001; Slater-Radosti et al., 2001; Fan et al., 2002;
Yazdankhah et al., 2006; Karatzas et al., 2007; Mima et al., 2007; Tkachenko
et al., 2007; Bailey et al., 2008; Webber et al., 2008; Chalew and Halden,
2009; Chen et al., 2009; McClellan and Halden, 2010; Yu et al., 2010; Saleh
et al., 2011; Bedoux et al., 2012).
concentrations, and suggested that TCS exposure leads to TCS-
resistance. Middleton and Salierno (2013) discovered that TCS
resistance was detected in 78.8% of fecal coliform samples from
streams receiving wastewater, and 89.6% of these samples were
resistant to four classes of antibiotics. Escherichia, Enterobacter,
Serratia, and Citrobacter were also found in the stream with
resistance to TCS and multiple antibiotics. This study investigated
real-world surface water samples which are implicitly associated
with many uncontrolled variables. Accordingly, it infers, but does
not prove, that TCS may be an external stressor that results in
increased abundance of resistance genes.
Studies on the impacts of TCS on anaerobic digesters, where
TCS is of highest abundance, are lacking. Lab-scale studies revea-
led that TCS can affect multidrug resistance genes in anaerobic
bioreactors. McNamara et al. (2014) found that TCS at 500 mg/kg
selected for mexB in lab-scale anaerobic digesters inoculated with
cow manure. In anaerobic digesters that were seeded with munic-
ipal biosolids, 500 mg/kg did not select for mexB, but methane
production was inhibited. It is not yet known if anaerobic
communities need to carry resistance genes in order to maintain
function at these high TCS levels. The findings indicated that the
microbial community structure, in addition to the concentration
of TCS, influences the selection of resistance genes. Also, this
research demonstrated that TCS can select for resistance, but
does selection happen at environmental concentrations of TCS?
Similarly, in activated sludge mesocosms, TCS selected for tetQ at
0.3 mg/L of TCS (Son et al., 2010). These two wastewater studies
found a correlation between the presence of a resistance gene and
TCS, but each study only investigated a single gene. A much more
thorough research effort is required to determine the breadth of
genes, with a special emphasis on multidrug resistance genes, that
are selected for when environmental concentrations of TCS are
applied to the complex microbial communities found in WWTPs.
It is also possible that TCS-resistant bacteria are formed in
premise plumbing which can feed into municipal WWTPs. In
a sink drain biofilm, TCS was shown to affect the bacterial
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population structure when a 0.2% (∼2000 mg/L) solution of soap
containing TCS was pumped over the biofilm (Mcbain et al.,
2003). Overall bacterial diversity was reduced and several TCS-
resistant bacteria related to Achromobacter xylosoxidans increased
in abundance, while other species including aeromonads, bacilli,
chryseobacteria, klebsiellae, stenotrophomonads, and Microbac-
terium phyllosphaerae were reduced. TCS in a drain following
consumer usage may result in resistant bacteria which are then
sent to WWTPs. Research is needed to determine if these bacteria
survive in the sewer system and whether these resistant bacteria
influence the resistance profile in WWTPs.
These studies show that TCS in the environment could select
for resistance genes. It seems likely that TCS resistance coin-
cides with TCS-derived cross-resistance to antibiotics in the
environment, but further studies are required to validate this
point.
RESEARCH GAPS AND CONCLUSIONS
It is noted that pathogenic bacteria, such as S. epidermidis,
are less susceptible to TCS today than they were in the past
(Skovgaard et al., 2013). Although resistance to TCS alone is
not a threat to human health, antibiotic resistance is a major
public health concern. TCS is widespread throughout the envi-
ronment, but the direct role of TCS on antibiotic resistance in
environmental systems is not yet defined. Four specific research
questions, which are outlined below, need to be answered to
identify the role of TCS on antibiotic resistance in environ-
mental systems and ultimately determine the impact on human
health.
IDENTIFY THE ROLE OF TRICLOSAN ON ANTIBIOTIC RESISTANCE IN
ENVIRONMENTAL SYSTEMS
What is the threshold concentration of TCS that triggers resistance?
Triclosan is found at a wide range of concentrations in a wide
range of environments (see Figure 2), and previous work found
that TCS can select for a resistance gene in a complex microbial
community (Son et al., 2010; McNamara et al., 2014). Moving
forward it is important to determine the concentrations of TCS
that trigger an increase in antibiotic resistance genes. Answering
this question will also help address the question framed by the lack
of data in Figure 2, i.e., what is the effect of TCS concentrations
below the MIC? Do low levels of TCS select for resistance? Chronic
exposure experiments using lab mesocosms should be performed
at a range of steady-state TCS concentrations. In most real world
cases, TCS levels will slowly increase, and lab experiments should
be designed to reflect this slow loading rate. TCS levels should
be slowly increased over time and held constant during steady-
state operation of the mesocosm to determine the concentration
of TCS that sustains changes in antibiotic resistance profiles.
Metagenomics can be used with the Antibiotic Resistance Genes
Database (Liu and Pop, 2009) to determine how the concentration
of TCS impacts the relative abundance of antibiotic resistance
genes. Additionally, qPCR can be employed to quantify changes
in resistance gene abundance. After completion of these exper-
iments we will have a better understanding about the concen-
trations of TCS that trigger increases in antibiotic resistance
genes.
What is the role of the microbial community composition on
TCS-derived antibiotic resistance?
Previous work revealed that the same concentration of TCS can
lead to different impacts on the abundance of a resistant gene
depending on the microbial community (McNamara et al., 2014).
Experiments outlined in the question above should be performed
on several different microbial communities. For example, com-
munities found in river sediments, soils, and anaerobic digesters,
should be investigated, and experiments should also be performed
on several different communities from each type of environment.
Wastewater communities can vary widely in their structure and
so could the impact of TCS on resistance in these communities.
Mesocosms should be inoculated with biosolids from several dif-
ferent cities to quantify how the same TCS concentrations impact
the antibiotic resistance profiles of different communities. Is there
a universal TCS concentration that is of concern in anaerobic
digester communities, in sediments, or in soils? Illumina sequenc-
ing on 16S rRNA genes should be performed as well to determine
if a link exists between certain microbes in a community and the
TCS-impacted resistance profile.
What is the impact of TCS on resistance profiles in environments
that are also perturbed by antibiotics?
Some resistance mechanisms, mainly efflux pumps, which are
triggered by TCS are also triggered by antibiotics. In environments
perturbed by TCS, antibiotics are also present (e.g., McClellan and
Halden, 2010). Does the presence of TCS impact the acquisition
of antibiotic resistance genes through horizontal gene transfer
when antibiotics are already present? In other words, if TCS were
not in these environments would the resistance profile look the
same? To help answer this question, mesocosms could be inoc-
ulated with complex microbial communities from environments
that are not heavily impacted by antibiotics or TCS. One set of
mesocosms could be amended with antibiotics and another set
would be amended with antibiotics and TCS. It is important to
add TCS and antibiotics at ratios typically found in the envi-
ronment. Granted, this question is difficult to answer because
complex microbial communities from pristine environments will
have inherent differences from the communities that are typically
exposed to TCS and antibiotics. Another possibility would be
to use a microbial community that has been widely exposed
to antibiotics but not exposed to TCS; this type of community
might be readily found in countries that have not adopted wide-
spread use of TCS. Molecular techniques described above could
be employed to determine the added impact of TCS on antibiotic
resistance gene profiles.
Will the abundance of resistance genes decrease if TCS
concentrations decrease?
It is important to know the concentrations of TCS that select
for resistance and the communities that are most vulnerable
to resistance caused by TCS, but it is equally important to
know if resistance caused by TCS is reversible. Mitigated use
of TCS has been proposed in the U.S. in part because of
the potential concerns over antibiotic resistance (Landau and
Young, 2014). If there were to be a sudden decline in con-
sumer usage, would TCS-resistance and associated multidrug
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resistance decrease? Experiments should be performed where
TCS is slowly increased to encourage TCS-resistance and the
mesocosms should be operated at steady-state with a constant
supply of TCS. After the resistance profiled is determined, TCS
should be removed from the system while the mesocosms are
maintained under TCS-free conditions. The resistance profile can
then be quantified after TCS is washed out of the mesocosms
to determine if TCS-derived resistance will decrease as TCS lev-
els decrease. This set of experiments would help to determine
the potential impacts of reducing TCS from environmental sys-
tems.
IDENTIFY THE IMPACT OF TRICLOSAN-DERIVED RESISTANCE IN THE
ENVIRONMENT ON PUBLIC HEALTH
Complex microbial environments can be highly conducive for the
transfer of resistance genes (Baquero et al., 2008). Locations with
high densities of bacteria, such as WWTPs, produce conditions
which are suitable for proliferation and exchange of resistance
genes, and TCS may be serving as a selective pressure to increase
the abundance of resistance genes in these communities. In a
study focusing on plasmid genes found in activated sludge, a wide
array of resistance genes, including genes that confer resistance to
TCS in pure cultures (mexB, and other efflux pump homologues
including acrB and smeE) were found on plasmids (Zhang et al.,
2011). Research is needed to address the fate of environmentally
derived resistance genes to understand how they impact human
health.
The fate and transport of these resistance genes in the envi-
ronment following discharge from WWTPs is not well defined.
Transport of genes can occur through direct uptake of DNA
(transformation), by viral infection (transduction), or by transfer
of plasmids and other mobile genetic elements (conjugation);
the resulting pathways for genetic transport are complicated to
constrain for modeling (Baquero et al., 2008). Genetic tracking of
resistance in the environment would require vast resources; using
established models of viruses or bacteria may be an appropriate
place to begin modeling resistance gene transport.
The rate of transfer of antibiotic resistance genes in the
environment to humans is also under investigation (Viau et al.,
2011; Ashbolt et al., 2013). Better understanding the threat of
environmentally derived antibiotic resistance genes on human
health is required to determine the role of TCS on public health.
Employing quantitative microbial risk assessment for antibiotic
resistance genes in environmental systems may be a useful avenue
for pursuing this topic.
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